Butterfly Network vs Qure.ai
Butterfly says it has distributed 3000+ probes for global health across 70+ countries with 400+ partners. A district hospital or NGO buying ultrasound for maternal and lung care would take the iQ+ at $2,699 (currency not stated). Butterfly's iQ3 page lists a B-lines counter, Auto Bladder, Cardiac Output, Umbilical Artery Doppler, Biplane, NeedleViz, Needle Out-of-Plane, Subxiphoid Tilt, iQ Slice and iQ Fan, and none of those names TB.
A TB screening program reading chest X-rays goes to Qure. Qure's about page cites a 2021 WHO endorsement for chest X-ray TB screening without a human reader, though none of its ten openFDA records is named for TB. An independent evaluation of 12 AI solutions for TB, listed on ResearchGate, put qXR v3 at 95.5% sensitivity and 48.7% specificity at one threshold. Qure's regulatory page lists ISO/IEC 27001, and qXR-LN (K231805) is cleared for radiologists, pulmonologists and ER physicians reading adult frontal chest radiographs for lung nodules.
Radiology · Reviewed November 2, 2026
Butterfly Network
by Butterfly Network, Inc.
Butterfly iQ handheld whole-body ultrasound probe line, with FDA-cleared AI tools for bladder volume and gestational age.
Qure.ai
by Qure.ai
AI for chest X-ray (qXR), head CT (qER) and lung nodule CT, with TB screening. The homepage cites sites across 107 countries.
When to pick each one
Butterfly Network
- Vendor reports 3000+ probes in 70+ countries
- iQ+ at $2,699, currency not stated
Qure.ai
- WHO endorsement cited by Qure, 2021
- ISO 27001 and ISO 13485 listed by Qure
- Ten FDA 510(k) records in openFDA
Score
Each row shows points earned of points available under the published rubric.
Butterfly Network
66of 100
Qure.ai
50of 100
| Dimension | Butterfly Network | Qure.ai | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 6 / 10 | 0 / 10 | +6 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 12.7 / 18.2 | 12.7 / 18.2 | 0 |
| RCT / meta-analysis / systematic review | 7.8 / 7.8 | 0 / 7.8 | +7.8 |
| Funding & adoption signal | 8.4 / 12 | 8.4 / 12 | 0 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Butterfly Network
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Butterfly iQ3 device | n/a | n/a | Device price, 3-year warranty. Shown with a dollar sign on the page, currency not otherwise stated. |
| Butterfly iQ+ device | n/a | n/a | Device price, 1-year warranty. Also stated as starts at $2,699 in the FAQ. |
| Core Technology membership | n/a | n/a | Plus probe. 1 seat, 2 probes online. |
| Advanced Technology membership | n/a | n/a | Plus probe. Adds Doppler modes, iQ Slice, iQ Fan, Biplane, Needle Viz and the AI tools Auto Bladder Volume and Auto B-Line Counter. |
| Advanced Technology one-time | n/a | n/a | Plus probe. Software access guaranteed for 5 years, no recurring fees required. |
Qure.ai
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Grant funding is not stated on Qure pages. |
Evidence
Butterfly Network
FDA decisions
K252148 (opens in new tab)510(k)2026-03-27
Butterfly Gestational Age Tool
K200980 (opens in new tab)510(k)2020-06-11
Auto 3D Bladder Volume Tool
Peer-reviewed
4 PubMed records name Butterfly Network.
- Comparison of in-person versus virtual ultrasound instruction for pediatric residents. (opens in new tab)
- Comparison of Six Handheld Ultrasound Devices by Pediatric Point of Care Ultrasound (POCUS) Experts. (opens in new tab)
- Breast assessment using next generation handheld ultrasound device based on silicon chips: a pilot study in senology. (opens in new tab)
Qure.ai
FDA decisions
K261517 (opens in new tab)510(k)2026-09-14
qCT Lung v1.0
K251934 (opens in new tab)510(k)2026-01-16
qXR-Detect
K251610 (opens in new tab)510(k)2025-09-08
qER-CTA v1.0
K240740 (opens in new tab)510(k)2024-08-16
qCT LN Quant
K231805 (opens in new tab)510(k)2023-12-22
qXR-LN
Show 5 more
K231149 (opens in new tab)510(k)2023-09-22
qXR-CTR
K230899 (opens in new tab)510(k)2023-08-22
qXR-PTX-PE
K212690 (opens in new tab)510(k)2021-12-21
qXR-BT
K211222 (opens in new tab)510(k)2021-07-30
qER-Quant
K200921 (opens in new tab)510(k)2020-06-17
qER
Peer-reviewed
4 PubMed records name Qure.ai.
- Radiograph accelerated detection and identification of cancer in the lung (RADICAL): a mixed methods study to assess the clinical effectiveness and acceptability of Qure.ai artificial intelligence software to prioritise chest X-ray (CXR) interpretation. (opens in new tab)
- Revolutionizing Healthcare: Qure.AI's Innovations in Medical Diagnosis and Treatment. (opens in new tab)
- A Case Series From a Multicentric Study: Can Artificial Intelligence (AI)-Enabled Chest X-Ray Assist in the Incidental Detection of Early-Stage Lung Cancers? (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Butterfly Network | Qure.ai |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | n/a |
| HQ | n/a | IN |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.